Provectus Pharmaceuticals, Inc.
7327 Oak Ridge Highway
Suite A
Knoxville,
TN 37931
United States - Map
Phone: 866-594-5999
Fax: 866-998-0005
Web Site: http://www.pvct.com
| Provectus Pharmaceuticals, Inc., a development stage company, specializes in oncology and dermatology therapies. The company is conducting Phase II clinical trials of its proprietary drugs PV-10 as a therapy for metastatic melanoma, and PH-10 as a topical treatment for psoriasis and atopic dermatitis. It received orphan drug designation from the FDA for its melanoma indication. In addition to its suite of proprietary drugs, Provectus Pharmaceuticals developed various intellectual properties and technologies in the areas of imaging, medical devices, and biotechnology. The company was founded in 2002 and is based in Knoxville, Tennessee. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. H. Craig Dees Ph.D., 57
Chairman, Chief Exec. Officer, Member of Audit Committee, Member of Nominating Committee, Chief Exec. Officer of Xantech of Xantech |
N/A
| N/A | Dr. Timothy Scott Ph.D., 50
Pres, Director, Member of Audit Committee, Member of Nominating Committee, Pres of Xantech of Xantech |
N/A
| N/A | Mr. Peter R. Culpepper CPA, MBA, 50
Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer and Sec. |
N/A
| N/A | Mr. Eric Wachter Ph.D., 46
Exec. VP of Pharmaceuticals, Director, Member of Audit Committee, Member of Nominating Committee, Exec. VP of Xantech Pharmaceuticals Inc of Xantech Pharmaceuticals Inc |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.14% Nasdaq 0.00%
Profile
